Livtencity (MARIBAVIR)

**Product type:** Human Prescription Drug

**Active ingredient:** MARIBAVIR

**Strength:** 200 mg/1

**Dosage form:** Tablet, Coated

**Route:** Oral

**Labeler:** Takeda Pharmaceuticals America, Inc.

**Marketing category:** NDA (NDA215596)

**Pharmacologic class:** Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Cytomegalovirus pUL97 Kinase Inhibitor [EPC], Cytomegalovirus pUL97 Kinase Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]